O66 A simulation based preceptorship for patients with rare and life threatening disease: working together with regional treatment centres to improve patient outcomes nationally

Author(s):  
T Dutt ◽  
A Brown ◽  
M Scully ◽  
C Kay Jones ◽  
J Marinas
Author(s):  
Xiaofan Huang ◽  
Dashuai Wang ◽  
Yu Song ◽  
Long Wu

Aortic dissection is an aggressive and life-threatening cardiac disease with highly challenging in surgical operation. Bentall procedure was potential complications. How to manage them would be important to improve patient outcomes. In this case, we present a 41-year-old male patient with iatrogenic aortic dissection. He had aortic valve replacement and repair of atrial septal defect in 2012. After 5 years, he suffered reoperation for aortic dissection. A year later the patient was readmitted for a voluminous pulsatile mass over the anterior thorax, confirming the presence of a huge pseudoaneurysm originating from the left coronary bottom performed during the Bentall procedure, requiring a third operation to repair the hemorrhagic site. The pseudoaneurysm was common complication after inclusion technique in Bentall procedure. How to effective hemostasis or tension-free anastomosis was important to improve patient outcomes.


2021 ◽  
Vol 10 (8) ◽  
pp. 1755
Author(s):  
Felicita Andreotti ◽  
Adelaide Iervolino ◽  
Eliano Pio Navarese ◽  
Aldo Pietro Maggioni ◽  
Filippo Crea ◽  
...  

Acute coronary syndromes (ACS) are a global leading cause of death. These syndromes show heterogeneity in presentation, mechanisms, outcomes and responses to treatment. Precision medicine aims to identify and synthesize unique features in individuals, translating the acquired data into improved personalised interventions. Current precision treatments of ACS include immediate coronary revascularisation driven by ECG ST-segment elevation, early coronary angiography based on elevated blood cardiac troponins in patients without ST-segment elevation, and duration of intensified antithrombotic therapy according to bleeding risk scores. Phenotypically stratified analyses of multi-omic datasets are urgently needed to further refine and couple the diagnosis and treatment of these potentially life-threatening conditions. We provide definitions, examples and possible ways to advance precision treatments of ACS.


2017 ◽  
Vol 33 (4) ◽  
pp. 296-302
Author(s):  
Madeline B. McCallister ◽  
Kelsy L. Fisher

Takayasu’s arteritis (TA) is a rare nonspecific inflammatory disease of unknown cause predominantly affecting the aorta and its main branches, coronary arteries, and pulmonary arteries of young females. Diagnosis of TA is typically achieved through computed tomography angiography (CTA) or magnetic resonance angiography (MRA), with sonography often used as a tool for surveillance of disease progression following diagnosis. A case of previously diagnosed TA is presented that demonstrates the effective use of sonography to monitor the progression of the disease with serial examination. The use of CTA and MRA allowed for accurate initial diagnosis, whereas sonography proved to be an effective diagnostic surveillance tool for proper tracking of the disease and its clinical manifestations. Increased sonographer awareness of TA including the clinical manifestations and sonographic characteristics associated with progression of the disease can improve patient outcomes in this potentially life-threatening disease.


Author(s):  
Sheri Palejwala ◽  
Jonnae Barry ◽  
Crystal Rodriguez ◽  
Chandni Parikh ◽  
Stephen Goldstein ◽  
...  

2012 ◽  
Vol 9 (2) ◽  
pp. 96-98
Author(s):  
Brian A Bruckner ◽  
Matthias Loebe

Patients undergoing re-operative cardiac surgical procedures present a great challenge with regard to obtaining hemostasis in the surgical field. Adhesions are ever-present and these patients are often on oral anti-coagulants and platelet inhibitors. As part of a well-planned surgical intervention, a systematic approach to hemostasis should be employed to decrease blood transfusion requirement and improve patient outcomes. Topical hemostatic agents can be a great help to the surgeon in achieving surgical field hemostasis and are increasingly being employed. Our approach, to these difficult patients, includes the systematic and planned use of AristaAH, which is a novel hemostatic agent whose use has proven safe and efficacious in our patient population.


Sign in / Sign up

Export Citation Format

Share Document